Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.

about

Factors Requiring Adjustment in the Interpretation of Serum Carcinoembryonic Antigen: A Cross-Sectional Study of 18,131 Healthy Nonsmokers.MicroRNA-466 with tumor markers for cervical cancer screening.

P2860

Q33741312-5F4304A3-FD1D-4FBA-9A19-8CC28B510D8F Q42378481-96621050-75A8-4726-8854-60CA468AF955

P2860

Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.

Item

http://www.wikidata.org/entity/Q38747437

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Serum tumor markers in chronic ...... ment and prognosis of cancers.

@en

type

Item

label

Serum tumor markers in chronic ...... ment and prognosis of cancers.

@en

prefLabel

Serum tumor markers in chronic ...... ment and prognosis of cancers.

@en

P1476

Serum tumor markers in chronic ...... ment and prognosis of cancers.

@en

P2093

Fateme Shamekhi Amiri

http://www.w3.org/2001/XMLSchema#string

P2860

Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells

β2-Microglobulin-mediated signaling as a target for cancer therapy

Afamin--A pleiotropic glycoprotein involved in various disease states

Screening, diagnosis, and treatment of cancer in long-term dialysis patients.

Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.

Proteomic signatures in plasma during early acute renal allograft rejection

Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers.

Characterization of β2-microglobulin expression in different types of breast cancer.

Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.

The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.

P304

530-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0886022X.2016.1148523

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26907957

http://www.w3.org/2001/XMLSchema#string

Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.

about

P2860

P2860

Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698